Two Sigma Investments
AGN

Two Sigma Investments’s Allergan Inc AGN Stock Holding History

Two Sigma Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-655,510
Closed -$139M – 3168
2014
Q4 		$139M Buy
655,510
+353,407
+117% +$70.3M 0.77% 8
2014
Q3 		$53.8M Buy
302,103
+118,831
+65% +$19.7M 0.24% 126
2014
Q2 		$31M Sell
183,272
-1,774
-1% -$276K 0.14% 212
2014
Q1 		$23M Buy
+185,046
New +$22.5M 0.12% 232
2013
Q4 		– Sell
-189,985
Closed -$17.2M – 2598
2013
Q3 		$17.2M Sell
189,985
-17,596
-8% -$1.58M 0.11% 232
2013
Q2 		$17.5M Buy
+207,581
New +$21.5M 0.12% 232

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Two Sigma Investments's AGN Position: Q1 2015 in Review

Two Sigma Investments sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 655,510 shares — an estimated $139M sold.

Two Sigma Investments first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $139M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Two Sigma Investments reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Two Sigma Investments sold 655,510 Allergan Inc shares in Q1 2015, an estimated $139M.
  • Two Sigma Investments first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Two Sigma Investments's Allergan Inc position peaked at $139M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.